Insights > Media

Media

CADE clarifies predatory pricing criteria

June 5th, 2019

Brazil’s competition authority has recommended that its tribunal find that Genzyme did not foreclose rivals from the market to supply dialysis medication.

Donwload

Related Partner

Bruno de Luca Drago

bdrago@demarest.com.br


Related Areas

Compliance and Investigations

Share

Media

SEE ALL

Media

Demarest advise Goldman Sachs on the acquisition of Symbiosis

April 17th, 2024

Media

NFT Auge, caída y evolución

April 3rd, 2024

Media

Demarest act as deal counsel on Ivi Energia issuance

March 28th, 2024

Media

Several firms advise on Anglo American joint venture with Vale

March 6th, 2024